Prof. FATMAHAN ATALAR

Metrics

Publication

121

Publication (WoS)

Publication (Scopus)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Education

2007 - 2008

Post Doctorate

Johannes Kepler Universitaet Linz, Engineering And Natural Sciences, Austria

2001 - 2002

Post Doctorate

Université Louis-Pasteur: Strasbourg I, Inserm Unite 424, France

1997 - 2001

Post Doctorate

University of Essex, Faculty Of Sciences And Health, School Of Biological Sciences, England

1994 - 1997

Doctorate

University of Essex, Faculty Of Science And Health, School Of Biological Sciences, United Kingdom

Dissertations

2000

Doctorate

Gene Trap Screening For Genes Expressed Preferentially In Low Serum Conditions

University of Essex, Bilim ve Sağlık Fakültesi, Biyolojik Bilimler

Foreign Languages

C1 Advanced

French

C1 Advanced

English

B1 Intermediate

Spanish

Certificates, Courses and Trainings

2020

European Joint Programme Rare Diseases-Online Workshop Implementing Biomedical Research Projects: The Complete Workflow from Concept, ELSI and Privacy Considerations to High-Quality Biobanking

Health&Medicine

European Joint Programme Rare Diseases

Research Areas

Life Sciences

Molecular Biology and Genetics

Genetic Disorders

Natural Sciences

Research Areas Based on Academic Activities

Avesis Research Areas

WoS Research Areas

Scopus Research Areas

Academic Positions

2023 - Present

Professor

Istanbul University, Instıtute of Chıld Health, Rare Diseases

2021 - Present

Associate Professor

Istanbul University, Istanbul Medical Faculty, Basic Medical Sciences

2019 - Present

Associate Professor

Istanbul University, Instıtute of Chıld Health, Dahili Tıp Bilimleri Bölümü

2014 - 2017

Professor

Muhimbili University of Health and Allied Sciences (MUHAS), Basic Sciences, Biochemistry

Managerial Experience

2022 - Present

Head of Department

Istanbul University, Instıtute of Chıld Health, Nadir Hastalıklar

2014 - 2018

Director of the Center

Muhimbili University of Health and Allied Sciences (MUHAS), Medical Faculty, Basic Medical Sciences/Biochemistry & Genetics

Non Academic Experience

2014 - 2018

Ziyaretçi Profesör

Muhimbili University of Health and Allied Sciences, Ziyaretçi Profesör

2014 - 2018

Genetik Laboratuvarı Kurucusu, Sorumlu Yönetici

Muhimbili University of Health and Allied Sciences, Genetik Laboratuvarı Kurucusu, Sorumlu Yönetici

2006 - 2014

Araştırma Görevlisi-Uzman

Johannes Kepler -Linz Üniversitesi, Araştırma Görevlisi-Uzman

2000 - 2002

Araştırma Görevlisi-Uzman

Charles Sadron Enstitüsü, Araştırma Görevlisi-Uzman

1997 - 2001

Araştırma Görevlisi-Uzman

Essex Üniversitesi, Araştırma Görevlisi-Uzman

Supervised Theses

in Progress

Doctorate

Genetic Screening for Hereditary Breast Cancer in Females and their First-Degree Relatives in Tanzania

Atalar F.

L.Rweyemamu(Student)

in Progress

Postgraduate

Tıp öğrencilerinin ve doktorların nadir hastalıklara ilişkin farkındalığı

Atalar F. (Advisor)

İ.Karagöz(Student)

2020

Doctorate

Investigation of 9p21.3 region in African Tanzanian Coronary Artery Disease Patients

Atalar F.

G.Akan(Student)

2018

Postgraduate

Investigation of clinical implication of soluble HLA-G and immunogenetic influence of HLA-G 3142G/C polymorphism in cervical and breast cancer development among patients attending ORCI in Tanzania

Atalar F.

I.Adolf(Student)

2007

Postgraduate

Regulation of PI3K/Akt Signalling Pathway in AML: A Novel Tumor-Supressor PHLPP

Atalar F. (Co-Advisor), Karabay Korkmaz A.

A.Tuğçe(Student)

Research Infrastructure Information

October 2021

Rare Diseases Research Laboratory

Advanced Research Laboratories - Directorate

Atalar F.

November 2014

Muhimbili Genetics Laboratory

Advanced Research Laboratories - Directorate

Atalar F.

Representation and Promotion Activities

Muhimbili İnsan Genetik Laboratuvarı Kurulması

Institutional Representation, Muhimbili Tıp Fakültesi, Tanzania, Dar-Es-Salaam, 2015 - 2018

Articles

2026

1. Expanding the Clinical Spectrum of Mitochondrial Phosphate Carrier Deficiency: A Case Report With Literature Review

Selamioglu A., ALTUN M., Bliven K., Ünverengil G., Güneş D., KARACA M., et al.

American Journal of Medical Genetics, Part A , vol.200, no.2, pp.438-445, 2026 (SCI-Expanded, Scopus)

2025

2. Alamandine enhanced spatial memory in rats by reducing neuroinflammation and altering BDNF levels in the hippocampus and prefrontal cortex

KILIÇ A., İPEK B. E., Tatonyan S., Kilic K., Demirci H., ATALAR F., et al.

Scientific Reports , vol.15, no.1, 2025 (SCI-Expanded)

2025

3. Enhancing Rare Disease Awareness and Education Among Medical Professionals and Students in Türkiye

Karagöz Ö., Tırtır B., Güneş D., Özgen Ö., Özçetin M., Gökçay G., et al.

Journal of Evaluation in Clinical Practice , vol.31, no.5, 2025 (SCI-Expanded, Scopus)

2025

4. Thyroid Hormone Dynamics and DIO2 Variants in Schizophrenia: Exploring Genetic Links to Neuroendocrine Imbalance

Akan G., Adolf I. C., Colak A., Acar S., Oncu F., Yesilbursa D., et al.

Journal of Cellular and Molecular Medicine , vol.29, no.13, 2025 (SCI-Expanded, Scopus)

2025

5. Development and validation of a carnitine cycle and transport disorders (CCD) panel: an ONT-compatible multi-gene diagnostic kit for newborn and selective screening.

Akan G., Balcı M. C., Tuncel G., Karaca M., Kazan H. H., Özketen A. Ç., et al.

Orphanet journal of rare diseases , vol.20, no.1, pp.250, 2025 (SCI-Expanded, Scopus)

2025

6. Benchmarking Nanopore Sequencing for CLN2 (TPP1) Mutation Detection: Integrating Rapid Genomics and Orthogonal Validation for Precision Diagnostics

Teker B., Akan G., Kazan H. H., ÖZGEN ÇOBAN Ö., Tatonyan S., BALCI M. C., et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , vol.26, no.11, 2025 (SCI-Expanded, Scopus)

2025

7. An Oxford Nanopore Technologies-Based Sequencing Assay for Molecular Diagnosis of Phenylketonuria and Variant Frequencies in a Turkish Cohort.

Tuncel G., Balcı M. C., Akan G., Kazan H. H., Özgen Ö., Özketen A. Ç., et al.

International journal of genomics , vol.2025, no.1, pp.5552662, 2025 (SCI-Expanded)

2025

8. Challenges in the clinical management of rare diseases and center-based multidisciplinary approach to creating solutions

Gunes D., Karaca M., Durmus A., Ak B., Aktay Ayaz N., Altınel Z. U., et al.

EUROPEAN JOURNAL OF PEDIATRICS , vol.184, no.5, 2025 (SCI-Expanded, Scopus)

2025

9. Alpha-mangostin and nab-paclitaxel in breast cancer cell models: improved antitumor efficacy through combination therapy.

Özgen Ö., Çetin İ., Atalar F., Topçul M. R.

Cellular and molecular biology (Noisy-le-Grand, France) , vol.71, no.1, pp.52-59, 2025 (SCI-Expanded)

2024

10. Oxidative damage and mitochondrial dysfunction in cystathionine beta-synthase deficiency

Balci M. C., GEDİKBAŞI A., Dogan S. A., Kahraman S., Tatoryan S., Neijmann S. T., et al.

Scientific Reports , vol.14, no.1, 2024 (SCI-Expanded)

2024

11. Oxford nanopore sequencing-based assay for BTD gene screening: Design, clinical validation, and variant frequency assessment in the Turkish population.

Kazan H. H., Karaca M., Akan G., Özgen Ö., Tuncel G., Özketen A. Ç., et al.

Gene , vol.928, pp.148782, 2024 (SCI-Expanded)

2024

12. The efficacy of high pressure liquid chromatography (HPLC) in detecting congenital glycosylation disorders (CDG)

Ozgen O., Güdek Klllç F., Gedikbaşl A., Balcl M. C., Karaca M., Durmuş A., et al.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , 2024 (SCI-Expanded)

2024

13. Severity of coronary artery disease is associated with diminished circANRIL expression: A possible blood based transcriptional biomarker in East Africa.

Akan G., Nyawawa E., Nyangasa B., Turkcan M. K., Mbugi E., Janabi M., et al.

Journal of cellular and molecular medicine , vol.28, no.3, 2024 (SCI-Expanded)

2023

14. Breast cancer in East Africa: Prevalence and spectrum of germline SNV/indel and CNVs in BRCA1 and BRCA2 genes among breast cancer patients in Tanzania

Rweyemamu L. P., Gultaslar B. K., Akan G., Dharsee N., Namkinga L. A., Lyantagaye S. L., et al.

CANCER MEDICINE , vol.12, no.3, pp.3395-3409, 2023 (SCI-Expanded)

2023

15. The interplay between XPG-Asp1104His polymorphism and reproductive risk factors elevates risk of breast cancer in Tanzanian women: A multiple interaction analysis

Adolf I. C., Rweyemamu L. P., Akan G., Mselle T. F., Dharsee N., Namkinga L. A., et al.

CANCER MEDICINE , vol.12, no.1, pp.472-487, 2023 (SCI-Expanded)

2022

16. HLA-G and single nucleotide polymorphism (SNP) associations with cancer in African populations: Implications in personal medicine

Adolf I. C., Almars A., Dharsee N., Mselle T., Akan G., Nguma I. J., et al.

GENES & DISEASES , vol.9, no.5, pp.1220-1233, 2022 (SCI-Expanded)

2022

17. Association of XRCC1-Arg399Gln and XPG-Asp1104His polymorphisms with reproductive risk factors and increased risk of breast cancer in Tanzanian patients

Adolf I. C., Akan G., Rweyemamu L. P., Atalar F.

EUROPEAN JOURNAL OF HUMAN GENETICS , vol.30, no.SUPPL 1, pp.377, 2022 (SCI-Expanded)

2021

18. The distribution of reproductive risk factors disclosed the heterogeneity of receptor-defined breast cancer subtypes among Tanzanian women

Rweyemamu L. P., Akan G., Adolf I. C., Magorosa E. P., Mosha I. J., Dharsee N., et al.

BMC WOMENS HEALTH , vol.21, no.1, 2021 (SCI-Expanded)

2021

19. Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia

Görmez S., Kırışoğlu Demir C. E., Ekicibasi M. E., Degirmencioglu A., Paudel A., Akan G., et al.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.49, no.4, pp.286-293, 2021 (ESCI)

2021

20. Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-1.

Gormez S., Gumusel H. K., Ekicibasi E., Degirmencioglu A., Paudel A., Akan G., et al.

Bratislavske lekarske listy , vol.122, no.8, pp.582-589, 2021 (SCI-Expanded)

2019

21. Relationships between visceral/subcutaneous adipose tissue FABP4 expression and coronary atherosclerosis in patients with metabolic syndrome.

GORMEZ S., ERDIM R., AKAN G., CAYNAK B., DURAN C., GUNAY D., et al.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology , vol.46, pp.107192, 2019 (SCI-Expanded)

2019

22. Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania.

Adolf I., Akan G., Mselle T., Dharsee N., Namkınga L., Atalar F.

Asian Pacific journal of cancer prevention : APJCP , vol.20, pp.3465-3472, 2019 (SCI-Expanded)

2019

23. Intronic variants in the long non-coding RNA CDKN2B-AS1 are strongly associated with the risk of coronary artery dise ase in the Northern Tribes of Tanzania.

Atalar F., Akan G., Janabi M.

Tanzania Journal of Health Research , vol.21, no.1, pp.1-14, 2019 (Scopus)

2019

24. Common SNP-based haplotype analysis of the 9p21.3 gene locus as predictor coronary artery disease in Tanzanian population

Akan G., Kisenge P., Sanga T. S., Mbugi E., Adolf I., Turkcan M. K., et al.

CELLULAR AND MOLECULAR BIOLOGY , vol.65, no.6, pp.33-43, 2019 (SCI-Expanded)

2016

25. Therapeutic potential of cyclooxygenase-3 inhibitors in the management of glioblastoma

Oksuz E., Atalar F., Tanirverdi G., Bilir A., Shahzadi A., Yazici Z.

JOURNAL OF NEURO-ONCOLOGY , vol.126, no.2, pp.271-278, 2016 (SCI-Expanded)

2015

26. herg1b Expression as a Potential Specific Marker in Pediatric Acute Myeloid Leukemia Patients with HERG 897K/K Genotype

Erdem M., Tekiner T. A., Fejzullahu A., Akan G., Anak S., Saribeyoglu E. T., et al.

PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.32, no.3, pp.182-192, 2015 (SCI-Expanded)

2015

27. PAI-1 and TNF-alpha profiles of adipose tissue in obese cardiovascular disease patients

Gazioglu S. B., Akan G., Atalar F., Erten G.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY , vol.8, no.12, pp.15919-15925, 2015 (SCI-Expanded)

2013

28. Mediastinal adipose tissue expresses a pathogenic profile of 11 β-hydroxysteroid dehydrogenase Type 1, glucocorticoid receptor, and CD68 in patients with coronary artery disease

Atalar F., Gormez S., Caynak B., Akan G., Tanriverdi G., Bilgic-Gazioglu S., et al.

CARDIOVASCULAR PATHOLOGY , no.3, pp.183-188, 2013 (SCI-Expanded)

2013

29. Growth Hormone/Insulin-Like Growth Factor-1 Axis as Related to Body Mass Index in Patients with Idiopathic Short Stature

Cengiz P., Bas F., Atalar F., Ucar A., Darendeliler F., Akan G., et al.

JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY , vol.5, no.1, pp.13-19, 2013 (SCI-Expanded, Scopus)

2013

30. OPN gene polymorphism (Ala250) and lower serum OPN levels are associated with urolithiasis

TUGCU V., SIMSEK A., Tarhan T., Atalar F., BITKIN A., TASCI A. I., et al.

RENAL FAILURE , vol.35, no.6, pp.825-829, 2013 (SCI-Expanded)

2013

31. Identification of a Novel BRCA2 and CHEK2 A-C-G-C Haplotype in Turkish Patients Affected with Breast Cancer

Haytural H., Yalcinkaya N., Akan G., ARIKAN S., Ozkok E., Cakmakoglu B., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.5, pp.3229-3235, 2013 (SCI-Expanded, Scopus)

2012

32. The role of mediastinal adipose tissue 11β-hydroxysteroid d ehydrogenase type 1 and glucocorticoid expression in the development of coronary atherosclerosis in obese patients with ischemic heart disease

Atalar F., Gormez S., Caynak B., Akan G., Tanriverdi G., Bilgic-Gazioglu S., et al.

CARDIOVASCULAR DIABETOLOGY , 2012 (SCI-Expanded)

2012

33. THE ASSOCIATION BETWEEN SERUM OSTEOPONTIN LEVELS AND OPN ALA 250 POLYMORPHISM IN UROLITHIASIS

Tarhan T., Tugcu V., Atalar F., Bitkin A., Sonmezay E., ALTUĞ T., et al.

JOURNAL OF ENDOUROLOGY , vol.26, 2012 (SCI-Expanded)

2012

34. No Effect of the IGF-1 Gene rs35767 and rs17032362 Polymorphisms in the Etiology of Idiopathic Short Stature

Tekcan D., Bas F., Atalar F., Aydin B. K., Akan G., Tarhan T., et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.120, no.7, pp.395-400, 2012 (SCI-Expanded, Scopus)

2012

35. 11 beta-hydroxysteroid dehydrogenase type 1 gene expression is increased in ascending aorta tissue of metabolic syndrome patients with coronary artery disease

Atalar F., Vural B., Ciftci C., Demirkan A., Akan G., Susleyici-Duman B., et al.

GENETICS AND MOLECULAR RESEARCH , vol.11, no.3, pp.3122-3132, 2012 (SCI-Expanded, Scopus)

2011

36. Adipose Tissue Gene Expression of Adiponectin, Tumor Necrosis Factor-alpha and Leptin in Metabolic Syndrome Patients with Coronary Artery Disease

GORMEZ S., DEMIRKAN A., Atalar F., Caynak B., ERDIM R., SÖZER V., et al.

INTERNAL MEDICINE , vol.50, no.8, pp.805-810, 2011 (SCI-Expanded)

2010

37. Two four-marker haplotypes on 7q36.1 region indicate that the potassium channel gene HERG1 (KCNH2, Kv11.1) is related to schizophrenia: a case control study

Atalar F., Acuner T. T., Çine N., Oncu F., Yesılbursa D., Ozbek U., et al.

BEHAVIORAL AND BRAIN FUNCTIONS , vol.6, 2010 (SCI-Expanded)

2009

38. A study on the prevalence of metabolic syndrome and the relation with polymorphism of a leptin receptor gene GIn223Arg in schizophrenia inpatients with and without treatment resistance

Oncu F., Atalar F., Acuner T. T., Turkcan S., Yesilbursa D., Uygur N.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , vol.19, 2009 (SCI-Expanded)

2009

39. CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children.

Baş F., Kayserili H., Darendeliler F., Uyguner O., Günöz H., Yüksel A., et al.

Journal of clinical research in pediatric endocrinology , vol.1, pp.116-28, 2009 (SCI-Expanded, Scopus)

2008

40. Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome

Vural B., Atalar F., Ciftci C., Demirkan A., Susleyici-Duman B., Gunay D., et al.

CARDIOVASCULAR PATHOLOGY , vol.17, no.6, pp.392-398, 2008 (SCI-Expanded, Scopus)

2008

41. Localization of the ergtoxin-1 receptors on the voltage sensing domain of hERG K+ channel by AFM recognition imaging

CHTCHEGLOVA L. A., Atalar F., Ozbek U., WILDLING L., EBNER A., HINTERDORFER P.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY , vol.456, no.1, pp.247-254, 2008 (SCI-Expanded)

2003

42. Bioactive coatings based on a polyelectrolyte multilayer architecture functionalized by embedded proteins

JESSEL N., Atalar F., LAVALLE P., MUTTERER J., DECHER G., SCHAAF P., et al.

ADVANCED MATERIALS , vol.15, no.9, pp.692-695, 2003 (SCI-Expanded)

Papers Presented at Peer-Reviewed Scientific Conferences

2024

1. Unmet Needs Of Caregivers For Rare Diseases: A Systematic Analysis Of Biotinidase Deficiency, Phenylketonuria, And Mucopolysaccharidoses. 2.

Atalar F.

Uluslararası İleri Araştırmalar Ve Uygulamalar Kongresi Sivas Cumhuriyet Üniversitesi , Sivas, Turkey, 19 September 2024, pp.114-115, (Full Text)

2024

2. DETERMINATION OF COGNITIVE AND NEUROPSYCHIATRIC EFFECT OF PHENYLKETONURIA AT EARLY TREATED ADULT PATIENTS; MR SPECTROSCOPY AND PHENYLALANINE LEVELS: PRELIMINARY RESULTS

KARACA M., KURT E., Kizilates Evin G., SELAMİOĞLU A., Canlı M., BALCI M. C., et al.

SSIEM 2024 Annual Symposium, Porto, Portugal, 3 - 06 September 2024, (Summary Text)

2024

3. Lysosomal Enzyme Activity Testing Process Quality Assurance During the Preanalytic- Analytic and Postanalytic Lab Phases

Gedikbaşı A., Kılıç Ş., Güneş D., Ak B., Çolak Aktaş Ü., Karaca M., et al.

24) SSIEM ANNUAL SUMPOSİUM, Porto, Portugal, 2 - 06 September 2024, pp.1, (Full Text)

2024

4. Circulating cell-free mitochondrial DNA as a proinflammatory DAMP for inherited hemolytic anemia

Tekin Neijmann Ş., GEDİKBAŞI A., Doğan Ş. A., Tatonyan S., BALCI M. C., Bekmez B., et al.

48th FEBS CONGRESS, Milan, Italy, 29 June 2024, pp.484, (Summary Text)

2024

5. Üre Döngüsü Bozukluğu Tanılı Çocukların Ebeveynlerinin Deneyimleri; Sosyodemografik Veriler Ve Karşılaşılan Zorluklar

Tırtır Yılmaz B., Balcı M. C., Karaca M., Atalar F., Gökçay G. F.

XVII. Uluslararası Katılımlı Metabolik Hastalıklar ve Beslenme Kongresi, Antalya, Turkey, 28 April - 02 May 2024, pp.289-290, (Summary Text)

2023

6. Retrospective Analysis Of Carbohydrate-Deficient Transferrin For CDG Screening: A Single Center Study

Özgen Ö., Güdek Kılıç F., Gedikbaşi A., Balci M. C., Karaca M., Durmuş A., et al.

SSIEM Annual Symposium 2023, Tel-Aviv-Yafo, Israel, 29 August 2023, vol.46, pp.257, (Summary Text)

2023

7. Rapid, accurate and comprehensive diagnostic method for the detection of Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease using long-read third-generation sequencing technology

Teker B., Tatonyan S., Balcı M. C., Karaca M., Akan G., Özgen Ö., et al.

SSIEM Annual Symposium 2023, Tel-Aviv-Yafo, Israel, 29 August - 01 September 2023, vol.46, no.686, pp.361, (Summary Text)

2023

8. Mitochondrial dysfunction in a disorder of transsulphuration: Cystathionine β-synthase deficiency

Balcı M. C., Gedikbaşı A., Kahraman S., Tatonyan S., Tekin Neijmann Ş., Karaca M., et al.

SSIEM Annual Symposium 2023, Tel-Aviv-Yafo, Israel, 29 August 2023, vol.46, pp.148, (Summary Text)

2023

9. Fluorometric Analysis and Validation of Tripeptidyl Peptidase-1 in Dry Blood Samples and Leukocytes in the Diagnosis of Neuronal Ceroid Lipofuxinosis 2

Teker B., Tatonyan S., Gedikbaşı A., Aydın A. F., Balcı M. C., Karaca M., et al.

VIII. Uluslararası Katılımlı Lizozomal Hastalıklar Kongresi, Bursa, Turkey, 3 - 07 May 2023, pp.64, (Summary Text)

2023

10. Mitokondriyal Aminoasilt-RNA Sentetaz Eksikligi Olgularinda Serum FGF-21 Düzeylerinin Degerlendirilmesi

Tekin Neijmann Ş., Gedikbaşı A., Güneş D., Balcı M. C., Karaca M., Atalar F., et al.

TÜRK KLİNİK BİYOKİMYA DERNEĞİ XXIII. Ulusal Klinik Biyokimya Kongresi, Antalya, Turkey, 27 - 30 April 2023, pp.234, (Summary Text)

2022

11. Prevalence and Spectrum of Germline SNV/indel and CNVs in BRCA1 and BRCA2 Genes among Breast Cancer Patients in Tanzania.

Rweyemamu L. P., Kurt Gültaşlar B., Akan G., Dharsee N., Namkinga L., Lyantagaye S., et al.

National Institute for Medical Research (NIMR) 31 st Annual Joint Scientific Conference, Dar-Es-Salaam, Tanzania, 6 - 08 May 2022, pp.324, (Summary Text)

2020

12. DIO2 Thr92Ala Reduces Deiodinase 2 Activity and Serum T3 Levels in Patients with Schizophrenia.

Atalar F., Özgen Ö.

European Human Genetics Virtual Conference, 6 June - 09 September 2020, pp.1164, (Summary Text)

2020

13. Circulating lncRNA ANRIL: a potential biomarker in Tanzanian patients with coronary artery disease

Atalar F., Akan G., Janabi M.

European Human Genetics Virtual Conference, Berlin, Germany, 6 - 09 June 2020, pp.1124, (Summary Text)

14. Epicardial Adipose Tissue Fatty Acid Binding Protein 4 Expression Is Correlated With Extension Of Coronary Atherosclerosis In Patients With Metabolic Syndrome

GORMEZ S., DEMIRKAN A., ATALAR F., CAYNAK B., GUNAY D., AKPINAR B., et al.

78th Congress of the European-Atherosclerosis-Society, Germany, pp.207, (Full Text)

2013

15. Association study of the DIO2 gene as a susceptibility candidate for schizophrenia in the Turkish population; a case-control study

Colak A., Akan G., Oncu F., Yanbay H., Acar S., Yesilbursa D., et al.

21st European Congress of Psychiatry, Nice, France, 6 - 09 April 2013, pp.196, (Full Text)

2011

16. İdiyopatik Boy Kısalığı Etiyopatogenezinde IGF-1 Gen Polimorfizmi Araştırılması

Tekcan D., Baş F., Atalar F., Akan G., Tarhan T., Darendeliler F.

33. Pediatri Günleri ve 12. Pediatri Hemşireliği Günleri, İstanbul, Turkey, 28 - 31 March 2011, pp.13, (Full Text)

2008

17. Antipsikotik İlaç Kullanımına Bağlı QTc Aralığının Uzamasında HERG Kanallarının Genetık ve Fonksiyonel Yönlerinin Araştırılması

Atalar F., Oncu F., Chtceglova L., Turkcan S., Yesilbursa D., Hinterdorfer P., et al.

Katılımlı VIII. Ulusal Tıbbi Genetik Kongresi, Çanakkale, Turkey, 6 - 09 May 2008, pp.124, (Full Text)

2009

18. A Significant Loss of Leucine Rich Repeat Domain in A Novel Candidate Tumour Suppressor Gene PHLPP in Cancer: Expression Studies

Tekiner T. A., Atalar F., Karabay A., Anak S., Özbek U.

European Society of Human Genetics Conference (ESHG) 2009, Vienna, Austria, 23 - 26 May 2009, pp.181, (Full Text)

2013

19. Expression of obesity related genes and leptin serum levels are decreased in Turkish schizophrenıa patients, case-control study

Akan G., Özgen Ö., Colak A., Acar S., Oncu F., Yesilbursa D., et al.

21st European Congress of Psychiatry, Nice, France, 6 - 09 April 2013, no.1043, pp.172, (Full Text)

2010

20. Çocukluk Çağı Obezitesinde IGF-1 Ve IGFBP-3 Genleri ile Lepin Gen Ekspresyonlarının Korelasyonunun Araştırılması

Atalar F., Baş F., Akan G., Tarhan T., Darendeliler F., Bundak R., et al.

XIV.Ulusal Pediatrik Endokrin ve Diyabet Kongresi, Muğla, Turkey, 4 - 10 October 2010, pp.122, (Full Text)

21. The Crosstalk Between the Insulin-Like Growth Factor (IGF)-IGF Binding Proteins Axis and Leptin: Differential Impact of Childhood Obesity in IGF-1, IGFBP-3 and Leptin

ATALAR F., BAŞ F., AKAN G., TARHAN T., DARENDELILER F., BUNDAK R., et al.

European Society For Paediatric Endocrinology (ESPE), United Kingdom, pp.553, (Full Text)

2004

22. Investigation of CYP21 gene mutations in congenital adrenal hyperplasia due to steroid 21 Hydroxilase Deficiency-old vs new diagnostic methods

Atalar F., Tükel T., Yüksel Apak M., Uyguner O., Kayserili H., Wollnik B.

VI. Ulusal Tibbi Genetik Kongresi, Antalya, Turkey, 21 - 24 April 2004, pp.53, (Full Text)

2011

23. Gene Expression of HERG1, HERG2, HERG3 Isoforms in Peripheral Blood Mononuclear Cells of Schizophrenia Patients

Atalar F., Acuner T. T., Colak A., Akan G., Tekiner T. A., Oncu F., et al.

3rd. European Conference on Schizohrenia Research-Facts and Visions, Berlin, Germany, 29 September - 01 October 2011, pp.60, (Full Text)

24. “Leptin, Leptin Receptor, MC4R, PPAR Gamma and Osteopontin Gene Polymorphisms in Obese and Overweight Children”

ATALAR F., BAŞ F., AKAN G., TARHAN T., DARENDELILER F., AYDIN B. K., et al.

49th Annual Meeting of the European Society of Pediatric Endocrinology (ESPE), Czech Republic, pp.79, (Full Text)

25. Pediyatrik Akut Myeloid Lösemi Progresyonunda Yeni Bir Tümor Süppressör: PHLPP

TEKINER T. A., ATALAR F., Karabay A., Anak S., ÖZBEK U.

VIII. Ulusal Tibbi Genetik Kongresi, Çanakkale, Turkey, pp.124, (Full Text)

26. Intraserebellar Siçan C6 Glioblastomada COX1, COX2 ve COX3 Düzeyleri Üzerine Asetaminofen, Metamizol ve İndometasinin Etkileri

Öksüz E., Köse A., Kula M., ATALAR F., Celik H., YAZICI Z.

19. Ulusal Farmakoloji Kongresi, Eskişehir, Turkey, pp.220, (Full Text)

27. The Combinatory effect of KCNH2/hERG1 K897T and DIO2 Thr92Ala in the Susceptibility to Schizophrenia

Colak A., AKAN G., ONCU F., YESILBURSA D., TURKCAN S., ATALAR F.

Molecular Immunology & Immunogenetics Congress, (MIMIC2012), Antalya, Turkey, pp.135, (Full Text)

28. FLT3-Receptor Thyrosine Kinase Activation Mediates Its Leukomogenic Effect Through WNT Signaling Pathway in AML patients

ATALAR F., SAYİTOĞLU M., HATIRNAZ O., ÖZBEK U.

30th World Congress of the International Society of Hematology, İstanbul, Turkey, pp.195, (Full Text)

29. Erken Obezite Tedavisi için Marker olan Pro12ALA Ppar? Ve VAL103ILE MC4R Polimorfizmlerinin Obez Çocuklardaki Sıklıklarının Araştırılması

Demir G., ATALAR F., BAŞ F., AKAN G., TARHAN T., DARENDELILER F., et al.

Endokrin Hastalıklar ve Genetik Sempozyumu, Bolu, Turkey, pp.90, (Full Text)

30. İdiyopatik Boy Kısalığı Hastalarında IGF-1, IGFBP-3 Düzeyleri ve Gen Ekspresyonlarının İlişkisi

Cengiz P., ATALAR F., BAŞ F., BUNDAK R., DARENDELILER F., AKAN G., et al.

XIII. Ulusal Pediatrik Endokrinoloji ve Diyabet Kongresi, Antalya, Turkey, pp.135, (Full Text)

31. “Expression of IGF-1, IGFBP-3, IGF-1R Genes in Idiopathic Short Stature

CENGIZ P., BAŞ F., BUNDAK R., ATALAR F., DARENDELILER F., AYDIN B. K., et al.

49th Annual Meeting of the European Society of Pediatric Endocrinology (ESPE), Czech Republic, pp.198, (Full Text)

32. PHLPP Gene is Mutated in Pediatric Acute Myeloid Leukemia Patients and Might Act as A Tumor Suppressor Gene

TEKINER T. A., ATALAR F., Karabay A., Anak S., ÖZBEK U.

European Society of Human Genetics (ESHG), Spain, pp.214, (Full Text)

33. PPAR Gamma Gene Expression is Positively Correlated with Leptin and MC4R Expressions in Congenital Adrenal Hyperplasia

ATALAR F., BAŞ F., TARHAN T., AKAN G., DARENDELILER F., BUNDAK R., et al.

50th Annual Meeting of the European Society of Pediatric Endocrinology (ESPE), United Kingdom, pp.172, (Full Text)

34. Bir Eğitim ve Araştırma Hastanesinde Genetik Çalışmak, Biyobankalamanın Örnek-İşlem Sürecinin Tasarlanması ve Deneyimler

ATALAR F.

45.Ulusal Psikiyatri Kongresi, Antalya, Turkey, pp.179, (Full Text)

35. Wnt Sinyal İleti Yolunun T-Hücreli ve B-Hücreli Akut Lenfoblastik Lösemilerde Farklı Aktivasyonları

SAYİTOĞLU M., HATIRNAZ O., ATALAR F., ERBİLGİN Y., ÖZBEK U.

XXXII. Ulusal Hematoloji Kongresi, Antalya, Turkey, pp.75, (Full Text)

36. The Critical Roles of STAMP2 and Proinflammatory Factor CD68 in Cardiometabolic Syndrome-Comparison of Genomic Findings with Clinical and Phenotypic Parameters”

ATALAR F., BILGIC-GAZIOGLU S., AKAN G., DEMIRKAN A., CAYNAK B., SAGBAS E., et al.

3rd ESF Functional Genomics Conference (ESFFG), Austria, pp.98, (Full Text)

37. Dysregulation Of Epicardial, Pericardial and Subcutaneous Adipokines in Obesity and Coronary Artery Disease

ATALAR F., GORMEZ S., CAYNAK B., GUNAY D., AKPINAR B., ÖZBEK U., et al.

European Human Genetics Conference (ESHG) 2011, Netherlands, pp.468, (Full Text)

38. Decreased WNT5A and FZ5 mRNA Levels contributes to Acute Lymphoblastic Leukemia (ALL)

SAYİTOĞLU M., HATIRNAZ O., ATALAR F., ÖZBEK U.

30th World Congress of the International Society of Hematology, İstanbul, Turkey, pp.196, (Full Text)

39. The prevalence of schizophrenia patients resistant and non-resistant to treatmentTedaviye Dirençli Olan ve Olmayan Şizofreni Hastalarında Metabolik Sendrom Sıklığı ve Leptin Reseptörü Geni Gln223arg Polimorfizmi ile İlişkisi

ONCU F., ATALAR F., ACUNER T. T., TURKCAN S., YESILBURSA D., Uygur N.

Bulletin of Clinical Psychopharmacology, Antalya, Turkey, pp.295, (Full Text)

40. Altered expression of Peroxysome Proliferator-Activated Receptor Gamma 2 and Serum Leptin Levels in Schizophrenia

AKAN G., Özgen Ö., ACUNER T. T., ONCU F., YESILBURSA D., TURKCAN S., et al.

European Human Genetics Conference (ESHG) 2011, Netherlands, pp.319, (Full Text)

41. Correlation of Leptin, Leptin Receptor Gene Polymorphism and Expression with Insulin Resistance in Congenital Adrenal Hyperplasia

BAŞ F., ATALAR F., DARENDELILER F., TARHAN T., AKAN G., AYDIN B. K., et al.

49th Annual Meeting of the European Society of Pediatric Endocrinology (ESPE), Czech Republic, pp.118, (Full Text)

42. Proinflamatuvar Bir Mediatör Olan Osteopontin ve Obezite

TARHAN T., ATALAR F., BAŞ F., AKAN G., Demir G., DARENDELILER F., et al.

Endokrin Hastalıklar ve Genetik Sempozyumu, Bolu, Turkey, pp.113, (Full Text)

43. Konjenital Adrenal Hiperplazi Vakalarında LEP ve LEPR Gen Polimorfizmlerinin İnsülin Direnci ile İlişkilendirilmesi

BAŞ F., TARHAN T., ATALAR F., AKAN G., Demir G., DARENDELILER F., et al.

XIII. Ulusal Pediatrik Endokrinoloji ve Diyabet Kongresi, Antalya, Turkey, pp.103, (Full Text)

2009

44. Leptin ve Leptin Reseptör Polimorfizmlerinin Çocukluk Çağı Obezitesi ile İlişkisi

Akan G., Atalar F., Baş F., Demir G., Tarhan T., Darendeliler F., et al.

XIII. Ulusal Pediatrik Endokrinoloji ve Diyabet Kongresi, Antalya, Turkey, 17 - 21 November 2009, pp.160, (Full Text)

2013

45. 11ß HSD-1 and PAI-1 Gene Expression Fructose Induced Metabolic Syndrome in Rats

Akan G., Inan O., Atalar F., Gormus U., Bilir A., Ozdilli K., et al.

12th FELASA SECAL Congress, Valencia, Spain, 19 - 22 June 2013, pp.109, (Full Text)

2009

46. Crosstalk Between T-Cadherin and Wnt/B-Catenin Pathways in Cancer

Fejzullahu A., Tekiner T. A., Erdem M., Anak S., Özbek U., Atalar F.

European Society of Human Genetics Conference (ESHG) 2009, Vienna, Austria, 23 - 26 May 2009, pp.166, (Full Text)

2011

47. The Association Between The Serum Osteopontin Levels and OPN Ala250 Polymorphism in Urolithiasis

Tarhan T., Atalar F., Tugcu V., Kural A. R., Bitkin A., Altuğ T.

European Human Genetics Conference (ESHG) 2011, Amsterdam, Netherlands, 28 - 31 May 2011, pp.178, (Full Text)

2009

48. Çocukluk Çağı Obez ve Erişkin Metabolik Bozuklukları olan Hastalarda Leptin ve Leptin Reseptörü Polimorfizmlerinin Serum Leptin Seviyeleri ile Karşılaştırılması

Akan G., Atalar F., Baş F., Demir G., Tarhan T., Bundak R., et al.

Endokrin Hastalıklar ve Genetik Sempozyumu, Bolu, Turkey, 8 - 10 October 2009, pp.112, (Full Text)

2008

49. Increased Expression of Vascular Endothelial Factor Receptor-1 and The Loss of Estrogen Receptor beta in Pediatric Acute Myeloid Leukemia Patients

Atalar F., Tekiner T. A., Özbek U.

3rd ESF Conference on "Functional Genomics and Diseases (ESFFG), Innsbruck, Austria, 1 - 04 October 2008, pp.98, (Full Text)

2008

50. Akut Miyeloid Lösemi’de Leptin Reseptör Geni İzoformlarının Ekspresyonu ve GLN223ARG Polimorfizmi

Atalar F., Özgen Ö., Özbek U.

VIII. Ulusal Tibbi Genetik Kongresi, Çanakkale, Turkey, 6 - 09 May 2008, pp.230, (Full Text)

2009

51. The prevalence of metabolic syndrome in schizophrenia patients using single versus multiple antipsychotic drugs

Oncu F., Acuner T. T., Atalar F., Turkcan S., Yesilbursa D., Uygur N.

III. Ulusal Psikofarmakoloji Kongresi, Antalya, Turkey, 12 - 15 March 2009, pp.292-295, (Full Text)

52. CYP21 Gene Mutations in Congenital Adrenal Hyperplasia due To 21-Hydroxylase Deficiency: Genotype-Phenotype Correlation in Turkish Children

ATALAR F., WOLLNIK B., DARENDELILER F., BAŞ F., GÜNÖZ H., KAYSERILI H., et al.

43rd Annual Meeting European Society for Paediatric Endocrinology, Switzerland, pp.109, (Full Text)

53. Konjenital Adrenal Hiperplazide Pro12Ala ve Val103 Polimorfizmlerinin İncelenmesi

TARHAN T., ATALAR F., BAŞ F., AKAN G., Demir G., DARENDELILER F., et al.

XIII. Ulusal Pediatrik Endokrinoloji ve Diyabet Kongresi, Antalya, Turkey, pp.124, (Full Text)

54. Abberant expression of the obesity hormone leptin and its receptor in epicardial adipose tissue of obese and CAD patients

AKAN G., GORMEZ S., CAYNAK B., YAZICI Z., GUNAY D., DURAN C., et al.

Molecular Immunology & Immunogenetics Congress, (MIMIC2012), Antalya, Turkey, pp.136, (Full Text)

55. Comparison Of Adipose Tissue Gene Expression Of Adiponectin, Tumor Necrosis Factor-A and Leptin In Patients With And Without Metabolic Syndrome

GORMEZ S., DEMIRKAN A., CAYNAK B., ATALAR F., GUNAY D., AKPINAR B., et al.

78th Congress of the European-Atherosclerosis-Society, Germany, pp.20, (Full Text)

56. Leptin Ve Leptin Regülatörlerinin Çocukluk Çağı Obezitesindeki Rollerinin Araştırılması

AKAN G., TARHAN T., ATALAR F., BAŞ F., DARENDELILER F., BUNDAK R., et al.

XIV.Ulusal Pediatrik Endokrin ve Diyabet Kongresi, Muğla, Turkey, pp.207, (Full Text)

2019

57. Implication of HLA-G+3142G>C Polymorphism and Soluble HLA-G in Mastectomized Breast Cancer Patients in Tanzania

Atalar F., Chatita A. I.

. 12th Conference of African Society of Human Genetics, Bamako, Mali, 19 September 2019 - 21 September 2020, pp.94, (Summary Text)

2018

58. Evaluation of Association Between Common SNPs on 9p21.3 Region and Coronary Artery Disease in Tanzanian Population.

ATALAR F., Mbugi E., Akan G., Janabi M., Kisenge P., Sanga T.

5th World Congress on Epigenetics and Chromosome, İstanbul, Turkey, 15 November - 16 October 2018, pp.74-75, (Full Text)

2018

59. Association of Chromosome 9p21.3 Region with Increased Risk of Coronary Artery Disease in Northern Tanzanian Patients.

Akan G., Mbugi E., Janabi M., Kisenge P., Sanga T., ATALAR F.

34th Turkish Cardiology Congress with International Participation, Antalya, Turkey, 20 - 23 October 2018, pp.145-147, (Full Text)

2018

60. Polymorphisms on Chromosome 9p21.3 Modify Susceptibility to Coronary Artery Disease and the Severity of Coronary Atherosclerosis in Tanzanian Population.

Akan G., Mbugi E., Janabi M., Kisenge P., Sanga T., ATALAR F.

11th Conference of the AfSHG - African Society of Human Genetics., Darüsselam, Tanzania, 19 - 21 September 2018, pp.19-20, (Full Text)

2018

61. Association of 9p21.3 With The Risk of Coronary Artery Disease in Tanzanian Patients

Akan G., Kisenge P., Mbugi E., Sanga T., Janabi M., ATALAR F.

The Sixth MUHAS Scientific Conference., Darüsselam, Tanzania, 2 - 03 July 2018, pp.114-116, (Full Text)

2018

62. Polymorphisms in 9p21.3 locus are associated with coronary artery disease in Northern Tanzanian patients.

Akan G., Mbugi E., Janabi M., Kisenge P., Sanga T., ATALAR F.

The Sixth MUHAS Scientific Conference., Darüsselam, Tanzania, 2 - 03 July 2018, pp.114-116, (Full Text)

2013

63. TNF alfa ile indüklenen mRNA ve serum PAl lEkspresyonunu Metaborik Sendrom Üzerine Etkisi

BİLGİÇ GAZİOĞLU S., AKAN G., ATALAR F., GÖRMEZ S., KAYNAK B., SÖZER V., et al.

5. Detae Günleri, Turkey, 11 - 12 November 2013

2013

64. TNF-α ILE İNDÜKLENEN PAI-1 mRNA EKSPRESYONU VE SERUM SEVIYESININ METABOLIK SENDROM ÜZERINE ETKISI

Bilgic-Gazioglu S., Akan G., Atalar F., Gormez S., Caynak B., Sozer V., et al.

22. Ulusal İmmünoloji Kongresi, İzmir, Turkey, 27 April 2013, pp.83, (Full Text)

2011

65. IGF-1 and IGFBP-3 Levels and Distribution of IGF-1 Gene Polymorphisms in Idiopatic Short Stature

Tekcan D., Baş F., Atalar F., Akan G., Tarhan T., Darendeliler F.

European Society For Paediatric Endocrinology (ESPE), Glasgow, England, 25 - 28 September 2011, vol.76, pp.694, (Summary Text)

2009

66. Obez Çocuklarda IGFBP-3 -202A/C Polimorfizmlerinin Serum IGFBP-3 ve IGF-1 Düzeyleri ile İlişkisi

Atalar F., Akan G., Baş F., Tarhan T., Demir G., Bundak R., et al.

Endokrin Hastalıklar ve Genetik Sempozyumu, Bolu, Turkey, 8 - 10 October 2009, pp.116, (Full Text)

2009

67. Alteration of HERG1 Isoform Expressions in Pediatric Acute Myeloid Leukemia and Solid Tumors: Expression Studies

Erdem M., Tekiner T. A., Fejzullahu A., Anak S., Özbek U., Atalar F.

European Society of Human Genetics Conference (ESHG) 2009, Vienna, Austria, 23 - 26 May 2009, pp.205, (Summary Text)

2007

68. WNT pathway mutations in acute leukemia patients

Sayitoglu M., HATIMAZ O., ATALAR F., ERBILGIN Y., OZBEK U.

12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.55, (Summary Text)

2007

69. Methylation status of the wnt antagonist DICKKOPF-1 gene in acute leukemias

ATALAR F., HATIRNAZ O., Sayitoglu M., ERBILGIN Y., OZBEK U.

12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.403, (Summary Text)

2007

70. Increased level of B-catenin mRNA and mutational alterations in APC gene are present in acute leukemia

ATALAR F., Sayitoglu M., HATIMAZ O., ERBILGIN Y., OZBEK U.

12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.62, (Summary Text)

2006

71. Different activation of WNT signaling pathway in B-cell and T-cell acute leukemias.

Sayitoglu M., HATIRNAZ O., Erbilgin Y., Atalar F., Ozbek U.

48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108, (Summary Text)

2006

72. Upregulation of FZ5 results in abberant expression of beta-catenin and LEF/TCF complex in acute myeloid leukemia.

Atalar F., Hatirnaz O., Erbilgin Y., Ozbek U., Sayitoglu M., Ozbek U.

48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108

2006

73. Kronik Lenfoblastik Lösemi Olgularında ZAP-70 Gen Ekspresyonunun RQ-PCR Yöntemi ile Tesbiti ve Prognostik Önemi

Coskunpınar E., Ure U., Baslar Z., Sayitoğlu M., Hatirnaz Ng Ö., Atalar F., et al.

XXXII. Ulusal Hematoloji Kongresi, Antalya, Turkey, 08 November 2006, pp.78, (Full Text)

2006

74. Yüksek FZ5 Ekspresyonu Beta-Catenin/TCF-LEF Kompleksinin Atipik Ekspresyonunu Arttırarak Akut Myeloid Lösemi Gelişiminde Rol Oynar

Atalar F., Sayitoğlu M., Hatirnaz Ng Ö., Erbilgin Y., Özbek U.

XXXII. Ulusal Hematoloji Kongresi, Antalya, Turkey, 8 - 12 November 2006, pp.76, (Full Text)

2006

75. 11 beta-HSD type 1 is responsible for low plasma hdl-cholesterol and abdominal obesity in metabolic syndrome patients

Atalar F., VURAL B., CIFTCI C., DEMIRKAN A., SUSLEYICI-DUMAN B., CAGATAY P., et al.

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.203

2006

76. Acylation stimulating protein and complement c3 mRNA expression in metabolic syndrome

DUMAN B. S., CIFTCI C., Atalar F., DEMIRKAN A., VURAL B., CAGATAY P., et al.

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.205

2006

77. Quantitative expression analysis of glucocorticoid receptor (GcR) gene in metabolic syndrome

DEMIRKAN A., Atalar F., VURAL B., DUMAN B. S., CIFTCI C., GUNAY G., et al.

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.204, (Summary Text)

2006

78. The role of FABP4 gene expression in metabolic syndrome patients with previous myocardial infarction

VURAL B., Atalar F., DEMIRKAN A., CIFTCI C., DUMAN B. S., CAGATAY P., et al.

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.204, (Summary Text)

Books

2008

1. General laboratory safety regulations

ATALAR F.

in: Genomik Uygulamalar, Özalpan A., Ünsal NP., Editor, T.C. İstanbul Kültür Üniversitesi Yayınları, İstanbul, pp.57-78, 2008

Funded Projects

2024 - Present

Kalıtsal Metabolizma Hastalıklarında Metabolomik ve Lipidomik Profilleme ile Laboratuvarda Geliştirilen Testler

Project Supported by Higher Education Institutions , University Supported Other Projects

GEDİKBAŞI A. (Executive), DENİZ N. G., ÇOLAK AKTAŞ Ü., BALCI M. C., KILIÇ Ş., KARACA M., et al.

2025 - 2026

Development and Clinical Validation of the Oxford Nanopore Platform-Specific Gene Panel for the Molecular Diagnosis of Treatable Lysosomal Storage Diseases

TUBITAK Project , 1000 - Üniversitelerin Araştırma ve Geliştirme Potansiyelinin Arttırılmasına Yönelik Destek Programı

(Project Abstract)

BALCI M. C. (Executive), GÖKÇAY G. F., ATALAR F.

2024 - 2026

Evaluation of The Use of Targeted Antiproliferative Agents with Albumin-Bound Paclitaxel in Different Breast Cancer Cell Lines with Cellular Molecular and Bioinformatic Approaches

Project Supported by Higher Education Institutions , BAP Other

Topçul M. R. (Executive), Atalar F., Çetin İ., Tavşanlı N., Erözden A. A., Özgen Ö., et al.

2023 - 2025

ARDIŞIK KÜTLE SPEKTROMETRİSİ İLE GENİŞLETİLMİŞ YENİDOĞAN TARAMASINDA İKİNCİ BASAMAK MOLEKÜLER AYIRICI TANI İÇİN ÜÇÜNCÜ YENİ NESİL DİZİLEME TEKNOLOJİSİ KULLANILARAK KİT GELİŞTİRME

Project Supported by Higher Education Institutions , University Supported Other Projects

(Project Abstract)

GÖKÇAY G. F. (Executive), DURMUŞ A., PAZHOUHESH R., SÖYLEMEZ S., TEKER B., ATALAR F., et al.

2022 - 2025

Hemoglobinopatilerde Okside Hemoglobin ve Mitokondriyal Hasar İlişkili Moleküler Paternler DAMPs ve NAD ile Antioksidanların İnvitro Potansiyel Terapötik Etkileri

Project Supported by Higher Education Institutions , BAP Other

KARAKAŞ Z. (Executive), ÖZBEÖZ O., TANYILDIZ H. G., GÖKÇAY G. F., ÖZHAN G., GEDİKBAŞI A., et al.

2023 - 2024

Depresyon Modeli Oluşturulan Sıçanlarda Alamandinin Kognitif Fonksiyonlara Ve Nöroinflamasyona Etkisi

TUBITAK Project , 1002 - Quick Support Program

Atalar F.

2020 - 2024

Breast cancer genes mutation analysis in the Hadzabe Ethnic group of Tanzania

Project Supported by Public Organizations in Other Countries

Atalar F.

2019 - 2022

Tanzanya'da kalıtsal meme kanseri olan kadın hastalar ve birinci derece akrabalarının genetik taraması

Project Supported by Public Organizations in Other Countries

Atalar F. (Executive)

2020 - 2021

COVID-19 için predispozan faktör olarak hipertansiyon ve kardiyovasküler hastalıkların rolü: Diğer etkenlere bağlı viral pnömonilerle karşılaştırma

Ministry of Health

Pamukçu B., Görmez S., Atalar F.

2020 - 2021

D-Dimer düzeyi normal COVID-19 hastalarında düşük moleküler ağırlıklı heparin tedavisinin hastane içi sonlanımlara ve prognostik laboratuvar parametreleri üzerine etkisini incelemek

Project Supported by Other Official Institutions

Pamukçu B., Görmez S., Atalar F.

2013 - 2017

7q36.1 Genom Bölgesindeki HERG1 (KCNH2, Kv11.1)?genin,n şizofreni hastaları ve kontrollerde RNA Dizilemesi ve Biyoinformatik Analizi

Project Supported by Higher Education Institutions , BAP Other

ATALAR F. (Executive)

2013 - 2013

7q36.1 Genom Bölgesindeki HERG1 (KCNH2, Kv11.1)?geninin şizofreni hastaları ve kontrollerde RNA Dizilemesi ve Biyoinformatik Analizi

Project Supported by Higher Education Institutions , BAP Other

ATALAR F. (Executive)

2010 - 2013

21 Hidroksilaz Eksikliğine bağlı konjenital adrenal hiperplazi vakalarında mutasyon aranması

Project Supported by Higher Education Institutions , BAP Research Project

ATALAR F. (Executive)

2011 - 2012

Şizofren hastalarının periferal kan hücrelerinde HERG1, HERG2 ve HERG3 izoformlarının ekspresyonu

Project Supported by Higher Education Institutions , BAP Other

ATALAR F. (Executive)

2009 - 2011

Çocukluk Çağı Akut Myeloid Lösemi'de Insülin benzeri büyüme faktörleri (IGF-1 ve IGF-2), Insülin benzeri büyüme faktörleri reseptörü (IGFIR) ve IGF bağlayan proteinlere bağlı proteinler (IGFBP-rP1) ile apoptoz ilişkisi

Project Supported by Higher Education Institutions , BAP Other

ATALAR F. (Executive)

2006 - 2007

Akut Myeloid Lösemi'de IGF Sisteminin Komponentlerini Oluşturan Genlerin IGF-1 ve 2 (Insulin-Like Growth Factor 1 ve 2) İle Reseptörlerinin Ekspresyonu: Apoptoz İle İlişkileri,

Project Supported by Other Official Institutions

ATALAR F. (Executive)

2004 - 2007

"MedGeNet; EURO-MEDITERRANEAN NETWORK FOR GENETİC SERVİCES Network

EU Framework Program Project

ATALAR F.

Activities in Scientific Journals

2023 - Present

FRONTIERS IN GENETICS

Assistant Editor/Section Editor

Memberships and Roles in Scientific Organizations

2023 - Present

Inborn error of metabolism genetics

Member

Peer Reviews in Scientific Publications

November 2025

FRONTIERS IN PEDIATRICS

Journal Indexed in SCI-E

September 2025

SCIENTIFIC REPORTS

Journal Indexed in SCI-E

August 2025

PLOS ONE

Journal Indexed in SCI-E

July 2025

ORPHANET JOURNAL OF RARE DISEASES

Journal Indexed in SCI-E

September 2022

JOURNAL OF KING SAUD UNIVERSITY - SCIENCE

SCI Journal

May 2022

Sabiad

National Scientific Refreed Journal

Mobility Activity

2007 - Present

Erasmus Programme

Scientific Research

Johannes Kepler Universitaet Linz, Austria

2014 - 2018

Bilateral Colloboration Agreement

Staff Mobility

Muhimbili University of Health and Allied Sciences (MUHAS), Tanzania

Congress and Symposium Activities

28 February 2023 - 28 February 2023

5. Nadir Hastalıklar Eğitim Toplantısı

Session Moderator

İstanbul-Turkey

02 February 2023 - 02 February 2023

EURORDIS Black Pearl awards Ceremony, online

Audience

Paris-France

01 June 2022 - 01 June 2022

Symposium Frontiers in Human exposome Research

Audience

Graz-Austria

28 May 2022 - 01 June 2022

XVI. Uluslararası Katılımlı Metabolizma Hastalıkları ve Beslenme Kongresi

Attendee

Hatay-Turkey

18 May 2022 - 20 May 2022

Nanopore- London Calling 2022

Attendee

London-England

17 April 2022 - 20 April 2022

44. Pediatri günleri ve 23. Pediatri Hemşireliği Günleri Kongresi

Moderator

İstanbul-Turkey

01 April 2022 - 01 April 2022

36. Marmara Metabolizma Grubu Toplantısı

Working Group

İstanbul-Turkey

04 March 2022 - 04 March 2022

35. Marmara Metabolizma Grubu Toplantısı

Working Group

İstanbul-Turkey

28 February 2022 - 28 February 2022

4. Nadir Hastalıklar Eğitim Toplantısı, online

Attendee

İstanbul-Turkey

28 February 2022 - 28 February 2022

2022 Global Rare Disease Day Event, “Rare Diseases: a Global priority for Equity”

Attendee

London-England

08 February 2022 - 08 February 2022

EURORDIS Black Pearl awards Ceremony, online

Audience

Paris-France

Invited Talks

May 2023